Alfonso Yubero

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 4

Top Topics

Peritoneal Dialysis

Squamous Cell Carcinoma

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Alba Moratiel-Pellitero, María Zapata-García, Marta Gascón-Ruiz, Andrea Sesma, Elisa Quílez, Ariel Ramirez-Labrada, Luis Martínez-Lostao, María Pilar Domingo, Patricia Esteban, Alfonso Yubero, Raquel Barbero-Herranz, Ana Moreno-Blanco, José Ramón Paño, Rodrigo Lastra, Julian Pardo, Dolores Isla, Rosa Del Campo, Eva M Galvez
Biomarkers of Immunotherapy Response in Patients with Non-Small-Cell Lung Cancer: Microbiota Composition, Short-Chain Fatty Acids, and Intestinal Permeability. Cancers 16 (6) (2024)
Alba Moratiel-Pellitero, María Zapata-García, Marta Gascón-Ruiz, Andrea Sesma, Elisa Quílez, Ariel Ramirez-Labrada, Luis Martínez-Lostao, María Pilar Domingo, Patricia Esteban, Alfonso Yubero, Raquel Barbero-Herranz, Ana Moreno-Blanco, José Ramón Paño, Rodrigo Lastra, Julian Pardo, Dolores Isla, Rosa Del Campo, Eva M Galvez
Biomarkers of Immunotherapy Response in Patients with Non-Small-Cell Lung Cancer: Microbiota Composition, Short-Chain Fatty Acids, and Intestinal Permeability. Cancers 16 (6) (2024)
Andrea Sesma, Julian Pardo, Dolores Isla, Eva M Galvez, Marta Gascón-Ruiz, Luis Martínez-Lostao, Alba Moratiel, J Ramón Paño-Pardo, Elisa Quílez, Irene Torres-Ramón, Alfonso Yubero, María Zapata-García, María Pilar Domingo, Patricia Esteban, Vicente Martín, Rodrigo Lastra, Ariel Ramirez-Labrada
Peripheral Blood TCRβ Repertoire, IL15, IL2 and Soluble Ligands for NKG2D Activating Receptor Predict Efficacy of Immune Checkpoint Inhibitors in Lung Cancer. Cancers 16 (16) (2024)
Andrea Sesma, Julian Pardo, Dolores Isla, Eva M Galvez, Marta Gascón-Ruiz, Luis Martínez-Lostao, Alba Moratiel, J Ramón Paño-Pardo, Elisa Quílez, Irene Torres-Ramón, Alfonso Yubero, María Zapata-García, María Pilar Domingo, Patricia Esteban, Vicente Martín, Rodrigo Lastra, Ariel Ramirez-Labrada
Peripheral Blood TCRβ Repertoire, IL15, IL2 and Soluble Ligands for NKG2D Activating Receptor Predict Efficacy of Immune Checkpoint Inhibitors in Lung Cancer. Cancers 16 (16) (2024)